Published
04/07/2026, 15:38The Eurasian Development Bank forecasts a new wave of investment following artificial intelligence — biotechnology, capable of extending active life expectancy and generating economic benefits worth trillions.
The Eurasian Development Bank analyses the dynamics of investment waves: digitalisation peaked in 2021, ESG in 2023, AI in 2025. The next likely wave will be biotechnology aimed at extending the healthy and economically active lives of the population. This approach not only extends life but also maintains labour force participation in older age, creating a powerful economic effect.
According to experts, one additional year of healthy life could yield results for the US and China equivalent to $15–$19 trillion in GDP growth over 20 years, and $2–$4 trillion for other leading economies.
EDB analysts note that investment waves form approximately every two years and act as catalysts for the emergence of new industries. Following digitalisation, ESG and AI, the next wave of biotechnology could become the next major driver of global economic growth.
